Novugen Pharma (USA) LLC
11 drugs in NADAC|11 Generic,0 Brand
Novugen Pharma (USA) LLC lists 11 NDCs in the CMS NADAC file (11 generic, 0 brand), at an average NADAC of $0.63 per unit, with a week-over-week move of -0.7% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
11
11G / 0B
Avg Price / Unit
$0.6321
$0.07 – $2.59
Avg 7d Change
-0.67%
Across 11 drugs with changes
7d Activity
of 11 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Sacubitril and Valsartan market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Angiotensin 2 Receptor Blocker therapeutic class
Review the broader class where Novugen Pharma (USA) LLC has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Novugen Pharma (USA) LLC make?
Novugen Pharma (USA) LLC lists 11 NDCs in the CMS NADAC file — 11 generic and 0 brand products.
What is the average price of Novugen Pharma (USA) LLC drugs?
The average NADAC across Novugen Pharma (USA) LLC's portfolio is $0.6321 per unit, ranging from $0.0737 to $2.5944.
What types of drugs does Novugen Pharma (USA) LLC make?
Novugen Pharma (USA) LLC makes drugs across 4 FDA pharmacologic classes. The most common by NDC count are Angiotensin 2 Receptor Blocker (6), Neprilysin Inhibitor (6), alpha-Adrenergic Agonist (3), Cytochrome P450 17A1 Inhibitor (2).
Has Novugen Pharma (USA) LLC had any drug recalls?
No FDA enforcement recalls are matched to Novugen Pharma (USA) LLC in the openFDA feed.
How has Novugen Pharma (USA) LLC's pricing changed recently?
Over the past 7 days, 5 Novugen Pharma (USA) LLC products rose and 6 fell, with a portfolio-wide average change of -0.7%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ABIRATERONE ACETATE 500 MG TAB abiraterone acetate | $2.5944 per EA | -6.26% |
ABIRATERONE ACETATE 250 MG TAB abiraterone acetate | $0.7741 per EA | -0.06% |
SACUBITRIL-VALSARTAN 97-103 MG Sacubitril and Valsartan | $0.5921 per EA | -0.18% |
SACUBITRIL-VALSARTAN 97-103 MG Sacubitril and Valsartan | $0.5921 per EA | -0.18% |
SACUBITRIL-VALSARTAN 49-51 MG Sacubitril and Valsartan | $0.5334 per EA | +0.80% |
SACUBITRIL-VALSARTAN 49-51 MG Sacubitril and Valsartan | $0.5334 per EA | +0.80% |
SACUBITRIL-VALSARTAN 24-26 MG Sacubitril and Valsartan | $0.4985 per EA | +0.13% |
SACUBITRIL-VALSARTAN 24-26 MG Sacubitril and Valsartan | $0.4985 per EA | +0.13% |
MIDODRINE HCL 10 MG TABLET Midodrine Hydrochloride | $0.1512 per EA | -1.79% |
MIDODRINE HCL 5 MG TABLET Midodrine Hydrochloride | $0.1113 per EA | -1.88% |
MIDODRINE HCL 2.5 MG TABLET Midodrine Hydrochloride | $0.0737 per EA | +1.13% |